Steve Creighton

Title: Innovations of Steve Creighton in Diagnostic Biochips

Introduction

Steve Creighton is an accomplished inventor based in Denver, Colorado. He has made significant contributions to the field of diagnostic technology, holding a total of four patents. His work primarily focuses on the development of biochips that utilize nucleic acid ligands for diagnostic purposes.

Latest Patents

Among his latest patents is the Nucleic Acid Ligand Diagnostic Biochip. This innovative diagnostic biochip comprises a solid support to which one or more specific nucleic acid ligands are attached in a spatially defined manner. Each nucleic acid ligand binds specifically and avidly to a particular target molecule contained within a test mixture, such as a bodily fluid. The biochip is designed to detect various target molecules, including proteins, hormones, sugars, and toxins. The binding of a target molecule to its cognate nucleic acid ligand results in a detectable change, which can be measured using devices like fluorescence scanners. This technology has the potential for wide applications, including environmental testing.

Career Highlights

Steve Creighton is currently employed at Somalogic, Incorporated, where he continues to advance his research in diagnostic technologies. His work has been instrumental in developing methods for the preparation and use of nucleic acid ligand biochips in diagnosing medical conditions.

Collaborations

Some of his notable coworkers include Larry M Gold and Sumedha D Jayasena, who have collaborated with him on various projects related to biochip technology.

Conclusion

Steve Creighton's innovations in the field of diagnostic biochips represent a significant advancement in medical technology. His contributions have the potential to improve diagnostic accuracy and broaden the applications of biochips in various fields.